These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 23331951)

  • 1. Cost-effectiveness of tubal patency tests.
    Verhoeve HR; Moolenaar LM; Hompes P; van der Veen F; Mol BW
    BJOG; 2013 Apr; 120(5):583-93. PubMed ID: 23331951
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost effectiveness of ovarian reserve testing in in vitro fertilization: a Markov decision-analytic model.
    Moolenaar LM; Broekmans FJ; van Disseldorp J; Fauser BC; Eijkemans MJ; Hompes PG; van der Veen F; Mol BW
    Fertil Steril; 2011 Oct; 96(4):889-94. PubMed ID: 21868001
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The FOAM study: is Hysterosalpingo foam sonography (HyFoSy) a cost-effective alternative for hysterosalpingography (HSG) in assessing tubal patency in subfertile women? Study protocol for a randomized controlled trial.
    van Rijswijk J; van Welie N; Dreyer K; van Hooff MHA; de Bruin JP; Verhoeve HR; Mol F; Kleiman-Broeze KA; Traas MAF; Muijsers GJJM; Manger AP; Gianotten J; de Koning CH; Koning AMH; Bayram N; van der Ham DP; Vrouenraets FPJM; Kalafusova M; van de Laar BIG; Kaijser J; van Oostwaard MF; Meijer WJ; Broekmans FJM; Valkenburg O; van der Voet LF; van Disseldorp J; Lambers MJ; Peters HE; Lier MCI; Lambalk CB; van Wely M; Bossuyt PMM; Stoker J; van der Veen F; Mol BWJ; Mijatovic V
    BMC Womens Health; 2018 May; 18(1):64. PubMed ID: 29743106
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reviewer's commentary on 'Cost-effectiveness of tubal patency tests'.
    Jacklin P
    BJOG; 2013 Apr; 120(5):593. PubMed ID: 23599963
    [No Abstract]   [Full Text] [Related]  

  • 5. [Comparative study on assessment of tubal patency among tubal insufflation, hydrotubation, hysterosalpingography and chromotubation under laparoscopy].
    Zuo W; Wang P
    Zhonghua Fu Chan Ke Za Zhi; 1996 Jan; 31(1):29-31. PubMed ID: 8758816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The cost-effectiveness of transvaginal hydrolaparoscopy versus hysterosalpingography in the work-up for subfertility.
    van Kessel MA; Pham CT; Tros R; Oosterhuis GJE; Kuchenbecker WKH; Bongers MY; Mol BWJ; Koks CAM
    Hum Reprod; 2022 Nov; 37(12):2768-2776. PubMed ID: 36223599
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-effectiveness of 'immediate IVF' versus 'delayed IVF': a prospective study.
    Eijkemans MJC; Kersten FAM; Lintsen AME; Hunault CC; Bouwmans CAM; Roijen LH; Habbema JDF; Braat DDM
    Hum Reprod; 2017 May; 32(5):999-1008. PubMed ID: 28204519
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-effectiveness of hysterosalpingography, laparoscopy, and Chlamydia antibody testing in subfertile couples.
    Mol BW; Collins JA; Van Der Veen F; Bossuyt PM
    Fertil Steril; 2001 Mar; 75(3):571-80. PubMed ID: 11239544
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chlamydial serology and histerosalpingography in predicting tubal disease in infertility patients.
    Fiçicioğlu C; Api M
    Acta Eur Fertil; 1995; 26(3):109-12. PubMed ID: 9098470
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integration of patient characteristics and the results of Chlamydia antibody testing and hysterosalpingography in the diagnosis of tubal pathology: an individual patient data meta-analysis.
    Broeze KA; Opmeer BC; Coppus SF; Van Geloven N; Den Hartog JE; Land JA; Van der Linden PJ; Ng EH; Van der Steeg JW; Steures P; Van der Veen F; Mol BW
    Hum Reprod; 2012 Oct; 27(10):2979-90. PubMed ID: 22851718
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fallopian tubal patency diagnosed by magnetic resonance hysterosalpingography.
    Ma L; Wu G; Wang Y; Zhang Y; Wang J; Li L; Zhou W
    J Reprod Med; 2012; 57(9-10):435-40. PubMed ID: 23091993
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-effectiveness of Chlamydia antibody tests in subfertile women.
    Fiddelers AA; Land JA; Voss G; Kessels AG; Severens JL
    Hum Reprod; 2005 Feb; 20(2):425-32. PubMed ID: 15539437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transvaginal hydrolaparoscopy versus hysterosalpingography in the work-up for subfertility: a randomized controlled trial.
    van Kessel M; Tros R; van Kuijk S; Oosterhuis J; Kuchenbecker W; Bongers M; Mol BW; Koks C
    Reprod Biomed Online; 2021 Aug; 43(2):239-245. PubMed ID: 34253451
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence-based medicine for diagnostic questions.
    Evers JL; Land JA; Mol BW
    Semin Reprod Med; 2003 Feb; 21(1):9-15. PubMed ID: 12806555
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pelvic factor infertility: diagnosis and prognosis of various procedures.
    Bulletti C; Panzini I; Borini A; Coccia E; Setti PL; Palagiano A
    Ann N Y Acad Sci; 2008 Apr; 1127():73-82. PubMed ID: 18443333
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hysterosalpingo-foam sonography, a less painful procedure for tubal patency testing during fertility workup compared with (serial) hysterosalpingography: a randomized controlled trial.
    Dreyer K; Out R; Hompes PG; Mijatovic V
    Fertil Steril; 2014 Sep; 102(3):821-5. PubMed ID: 24996498
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of tubal abnormalities by HSG in Nepalese subfertile women.
    Shrivastava VR; Rijal B; Shrestha A; Shrestha HK; Tuladhar AS
    Nepal Med Coll J; 2009 Mar; 11(1):42-5. PubMed ID: 19769237
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The capacity of transvaginal hydrolaparoscopy versus hysterosalpingography to diagnose tubal pathology in the work-up of subfertile women, a randomised clinical trial.
    Tros R; van Kessel MA; van Kuijk SMJ; Oosterhuis GJE; Kuchenbecker WKH; Kwee J; Bongers MY; Mol BWJ; Koks CAM
    Eur J Obstet Gynecol Reprod Biol; 2019 May; 236():127-132. PubMed ID: 30903885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identifying subfertile ovulatory women for timely tubal patency testing: a clinical decision rule based on medical history.
    Coppus SF; Verhoeve HR; Opmeer BC; van der Steeg JW; Steures P; Eijkemans MJ; Hompes PG; Bossuyt PM; van der Veen F; Mol BW
    Hum Reprod; 2007 Oct; 22(10):2685-92. PubMed ID: 17675647
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fertility-related quality of life in subfertile women undergoing tubal testing with transvaginal hydrolaparoscopy or hysterosalpingography.
    van Kessel MA; Paulussen M; Tros R; Bongers MY; Mol BWJ; Koks CAM
    Eur J Obstet Gynecol Reprod Biol; 2022 Jul; 274():19-22. PubMed ID: 35561566
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.